HIGHLIGHTS
- who: Olof Hjorth from the (UNIVERSITY) have published the Article: Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy, in the Journal: (JOURNAL) of 13/09/2022
- what: Since the clinical measures of the full cohort has already been evaluated , the aim of this study was not to verify differential treatment efficacy, but to evaluate if monoaminergic transporter mechanisms underlying symptom improvement differ between the two treatment modalities.
SUMMARY
Social anxiety disorder (SAD) is a debilitating and chronic psychiatric disorder associated with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.